Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by SweetSmackerson Jan 11, 2018 11:11pm

253 Views

Post# 27339185

NEW AGE FARMS CALLING ON PARTNERS...

IT'S INEVITABLE THAT THEY ARE GOING TO FORMULATE A KEY PARTNERSHIP THAT WILL BLOW THE ROOF OFF OF THIS SP. THEY ARE IN THE RIGHT SECTOR AND THERES NO TIME LIKE THE PRESENT LET'S SEE IF WE GET SOME STEROIDS FOR THE SP THIS YEAR! RIDE THE LEGALIZATION BULL HARD !! GO BABY!!
GROW HARD OR GO HOME!

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December